Pandemic Preparedness
Accelerating research, advocating for equity, and preparing for future pandemics
Pandemic Preparedness
Accelerating research, advocating for equity, and preparing for future pandemics
Our not-for-profit drug discovery and development experience, as well as our collaborative, open-science model, can help prepare for future pandemics.
We are participating in several ambitious drug discovery projects focused on coronaviruses, flaviviruses, and enteroviruses to identify new drug candidates for the treatment of diseases of pandemic potential, such as MERS, dengue, Zika fever, and yellow fever.
Our approach is focused on ensuring the needs of vulnerable communities are not forgotten. The COVID-19 pandemic threw longstanding global health inequalities into stark relief. Wealthy countries had access to advanced vaccines and therapeutics as soon as they were approved while many low- and middle-income countries were left grasping for basic supplies. It is more important than ever to prepare for future viral pandemics by strengthening global health R&D systems and ensuring the principles of access, affordability, and equity are embedded in the R&D process itself.
What we are doing for pandemic preparedness
We are using our experience in non-profit drug development and our partnerships with medical research institutions worldwide to prepare for future viral pandemics in low- and middle-income countries.
What we have achieved
We engaged in collaborative drug discovery partnerships to develop affordable, effective new COVID-19 treatments. We also mobilized partners around the world, particularly in low- and middle-income countries, to build clinical trials networks, share knowledge, and conduct research with a particular focus on finding solutions for low-resource settings.
Pandemic preparedness news & resources
Stay connected
Get our latest news, personal stories, research articles, and job opportunities.
